Gonorrhea and Chlamydia HIV-infected Men Who Have Sex With Men
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02019771|
Recruitment Status : Completed
First Posted : December 24, 2013
Last Update Posted : August 21, 2017
Hypothesis: Men who have sex with men (MSM) are at higher risk for sexually transmitted diseases. Currently, free testing for sexually transmitted diseases is only being performed in urine samples. Investigators hypothesize that the rates of both gonorrhea and chlamydia will be higher when testing includes more than one anatomical site (rectum and oropharynx).
The aim of the study is to estimate the rates of asymptomatic Chlamydia and/or Gonorrhea in the oropharynx, rectum and urethra (urine) of HIV infected men who have sex with men at the specialty care center of the University of Nebraska Medical Center and compare to the rates in Douglas County, using nucleic acid amplification tests.
|Condition or disease|
|HIV Infection Chlamydia Gonorrhea|
|Study Type :||Observational|
|Actual Enrollment :||150 participants|
|Official Title:||Prevalence of Gonorrhea and Chlamydia Infections in Multiple Anatomical Sites in HIV-infected Men Who Have Sex With Men at an HIV Clinic in Omaha, Nebraska|
|Study Start Date :||January 2014|
|Actual Primary Completion Date :||October 2014|
|Actual Study Completion Date :||October 2014|
- Chlamydia or gonorrhea infection [ Time Frame: one day ]Investigators will use nucleic acid amplification tests in urine, rectal and oropharyngeal swab specimens to detect asymptomatic chlamydia and/or gonorrhea infection
- accuracy for detecting infection when using one versus 2 versus 3 anatomical sites [ Time Frame: 1 day ]Investigators will compare the proportion of infections detected by using only urine, only rectum, only oropharynx vs. using combined sites (urine and rectum, urine and oropharynx or oropharynx and rectum) vs. using all 3 sites.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02019771
|United States, Nebraska|
|Specialty Care Center|
|Omaha, Nebraska, United States, 68198-8106|
|Principal Investigator:||Uriel S Sandkovsky, MD||University of Nebraska|